| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Sep―02 |
Human E3 ubiquitin ligases: accelerators and brakes for SARS-CoV-2 infection |
Jesse Pellman, Anna Goldstein, Mikołaj Słabicki |
| 2 |
[GO] |
2023―Dez―18 |
Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection |
Debjit Khan, Paul L. Fox |
| 3 |
[GO] |
2023―Jun―09 |
Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence |
Xiyuan Bai, Tony Schountz, Ashley M. Buckle, Janet L. Talbert, Robert A. Sandhaus, Edward D. Chan |
| 4 |
[GO] |
2023―Mai―18 |
Mechanisms of impairment of interferon production by SARS-CoV-2 |
Huy-Dung Hoang, Parisa Naeli, Tommy Alain, Seyed Mehdi Jafarnejad |
| 5 |
[GO] |
2022―Nov―24 |
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination |
Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O'Hehir, Menno C. van Zelm |
| 6 |
[GO] |
2022―Jan―11 |
Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases |
Anoop Narayanan, Shay A. Toner, Joyce Jose |
| 7 |
[GO] |
2021―Dez―02 |
The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines |
Kensaku Murano, Youjia Guo, Haruhiko Siomi |
| 8 |
[GO] |
2021―Aug―05 |
Host ADP-ribosylation and the SARS-CoV-2 macrodomain |
Nicolas C. Hoch |
| 9 |
[GO] |
2021―Mrz―05 |
Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter? |
Devanshi Mishra, Chinmoy Sankar Dey |
| 10 |
[GO] |
2020―Dez―24 |
Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies |
Ilaria Manfredonia, Danny Incarnato |
| 11 |
[GO] |
2020―Dez―01 |
A pocket guide on how to structure SARS-CoV-2 drugs and therapies |
Dene R. Littler, Bruce J. MacLachlan, Gabrielle M. Watson, Julian P. Vivian, Benjamin S. Gully |
| 12 |
[GO] |
2020―Nov―10 |
Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications |
Jiayue-Clara Jiang, Yan Zhang |
| 13 |
[GO] |
2020―Okt―21 |
Transmission and prevention of SARS-CoV-2 |
Zhongyi Wang, Yingying Fu, Zhendong Guo, Jiaming Li, Jingjing Li, Hongliang Cheng, et al. (+2) Bing Lu, Qiang Sun |
| 14 |
[GO] |
2020―Jun―08 |
α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19 |
Spencer J. Williams, Ethan D. Goddard-Borger |
